Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Intrauterine Growth Restriction clinical trials

2 of 3 indexed Intrauterine Growth Restriction trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Intrauterine Growth Restriction: 3 US clinical trials tracked, 2 recruiting.

Intrauterine Growth Restriction is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Mirvie, running 1 of these trials.

Enrollment posture brief

Registry condition intrauterine-growth-restriction

OPEN 2 | RECR 67% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Intrauterine Growth Rest (th…67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Intrauterine Growth Restriction

Intrauterine Growth Restriction lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intrauterine Growth Restriction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intrauterine Growth Restriction is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Intrauterine Growth Restriction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mirvie Predictive Test for Adverse Pregnancy Outcomes Diagnostic test
1 trials
Oxygen Other
1 trials
PEAPOD Infant Body Composition measuring device Device
1 trials

US sites by state

Facility locations filed on Intrauterine Growth Restriction trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Wisconsin 1 trials
Washington 1 trials
Texas 1 trials
Pennsylvania 1 trials
Ohio 1 trials
Missouri 1 trials
Louisiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intrauterine Growth Restriction page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Intrauterine Growth Restriction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mirvie sponsors the most Intrauterine Growth Restriction trials on record, review their full trial history before evaluating a specific study. See Mirvie's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intrauterine Growth Restriction condition card totals 3 registered trials; most-linked intervention Mirvie Predictive Test for Adverse Pregnancy Outcomes; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.